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Abstract
The chromatin remodeling protein ATRX, which targets tandem repetitive DNA, has been shown to be required for
expression of the alpha globin genes, for proliferation of a variety of cellular progenitors, for chromosome congression and
for the maintenance of telomeres. Mutations in ATRX have recently been identified in tumours which maintain their
telomeres by a telomerase independent pathway involving homologous recombination thought to be triggered by DNA
damage. It is as yet unknown whether there is a central underlying mechanism associated with ATRX dysfunction which can
explain the numerous cellular phenomena observed. There is, however, growing evidence for its role in the replication of
various repetitive DNA templates which are thought to have a propensity to form secondary structures. Using a mouse
knockout model we demonstrate that ATRX plays a direct role in facilitating DNA replication. Ablation of ATRX alone,
although leading to a DNA damage response at telomeres, is not sufficient to trigger the alternative lengthening of
telomere pathway in mouse embryonic stem cells.
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Introduction
ATRX is an SNF2-related chromatin remodelling protein
which acts with the histone chaperone DAXX to insert the variant
histone H3.3 into telomeric and pericentromeric heterochromatin
[1,2]. Constitutional mutations in ATRX give rise to alpha
thalassaemia mental retardation, X-linked (ATR-X) syndrome [3].
The affected males exhibit severe intellectual disability, and
multiple congenital abnormalities involving genital and skeletal
development, as well as a characteristic facial appearance and
many have alpha thalassaemia an anaemia which, in these
individuals, is due to reduced alpha globin gene expression.
Extensive studies in mouse have shown that absence of full- length
ATRX leads to defective development of the trophoblast [4], loss
of neurons in the CNS [5], lack of proliferation of myoblasts [6]
and Sertoli cells [7] as well as abnormal mitosis [8] and meiosis
[9]. It is unclear however how all these diverse effects result from
ATRX dysfunction.
An important recent finding is that ATRX localises to G-rich
tandem repeats including interstitial repeats and telomeres during
S phase [10]. These sequences are thought to form secondary
structures such as G quadruplex (G4) and indeed ATRX binds G4
in vitro. In the absence of ATRX there is an increase in DNA
damage at telomeres [11] raising the possibility that ATRX is
required for the replication of these unusual DNA templates and
that ATRX deficiency leads to replicative stress.
Here we confirm and extend these important observations in a
primary mouse cell line knocked out for ATRX and demonstrate a
defect in S phase progression following an aphidicolin block,
sensitivity to hydroxyurea, increased stalling of replication and an
increase in double strand breaks (DSBs) as detected by 53BP1 foci
and a neutral comet assay. These aspects of ATRX function may
be particularly important at telomeres. It has previously been
shown that, in telomerase negative tumour cells, viability is
maintained via an alternative pathway (ALT) to lengthen
telomeres. Furthermore, tumours with the ALT phenotype
frequently harbour acquired somatic mutations in the ATRX
gene [12,13,14]. Importantly, here we show that disruption of
ATRX alone, in mouse embryonic stem cells, is not sufficient to
trigger ALT and consequently other factors must contribute to this
pathway. Here we used co-immunoprecipitation and co-localisa-
tion, to identify other factors that interact with ATRX and found
that in wild-type cells, endogenous ATRX associates with the
MRN complex which is also known to play a part in generating
the ALT phenotype. This study has further developed the
evidence showing that ATRX plays a direct role in DNA repair,
and together with MRN, may play an important role in the ALT
pathway.
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Results
Knockout of ATRX induces a DNA damage response in
mouse embryonic stem cells
We have previously generated mouse embryonic stem (mES)
cell lines conditionally deleted for full length ATRX (Atrxnull) with
their wildtype counterparts (Atrxflox) mES cells [4]. Using these cell
lines we sought to further characterise the cellular function of
ATRX. In agreement with previous reports, loss of ATRX was
associated with an increased DNA damage response, as detected
by an increase in 53BP1 foci as well as an increase in telomeric
53BP1 foci (Figure 1A, B and C). We confirmed a higher
frequency of DSBs, specifically, in the ATRX knockout using a
neutral comet assay (Figure 1D and E). To investigate the origin of
the increased DSBs in the ATRX knockout cells, clonogenic
sensitivity assays were performed with a range of DNA damaging
agents and DNA replication inhibitors. There was a modest
increase in sensitivity in the Atrxnull cells upon treatment with the
DNA replication stress inducing drug hydroxyurea (HU) but no
response to other DNA replication inhibitors (camptothecin and
aphidicolin) or DNA damaging agents (gamma-irradiation (IR)
and cisplatin) (Figure 1F). Whilst camptothecin inhibits topoisom-
erase I and aphidicolin inhibits DNA polymerase, HU inhibits
DNA replication by depleting dNTPs, resulting in extended
regions of single-stranded DNA [15], likely leading to an increased
probability of forming G4 structures. The specific sensitivity of the
Atrxnull cells to HU is therefore consistent with a role for ATRX in
processing G4 structures, as previously hypothesised [16].
ATRX is required for proficient S phase progression by
limiting fork stalling
The existence of a DNA replication defect upon loss of ATRX
was confirmed in a number of ways. Atrxflox and Atrxnull mES cells
were blocked at the G1/S boundary with aphidicolin, released,
and the progression through S-phase was monitored by fluores-
cence activated cell sorting (FACS) showing that S-phase was
markedly prolonged in the Atrxnull cells (Figure 2A and B).
Interestingly, 6–10 hours post block an increased number of cells
(,20%) staining for BrdU in-between the S and G2 populations in
the Atrxnull cells became evident, most likely indicating a defect in
late S-phase (Figure 2A, Figure S1A and S1B). Moreover, Western
blots prepared from histones extracted in parallel and blotted for
gamma-H2AX demonstrated that the prolonged S-phase in
Atrxnull cells was correlated with an elevated DDR in comparison
to the Atrxflox cells, despite a similar initial DDR after aphidicolin
treatment (Figure 2C and D). Comparable results were obtained
with independently isolated Atrxflox and Atrxnull clones, excluding
the possibility that these differences were attributable to clonal
variations (Figure S1C and S1D). We have previously reported
that unchallenged, asynchronous Atrxnull mES cells do not show
alterations in cell cycle profile relative to wild type cells [4],
suggesting that an aphidicolin block potentiates a more severe
replication defect upon loss of ATRX.
Replication fork progression was next analysed at single
molecule resolution using DNA fibre analysis, a technique in
which replicating cells are sequentially labelled with nucleotide
analogues (iododeoxyuridine (IdU) and chlorodeoxyuridine
(CldU)), lysed, the DNA fibres spread on glass slides, probed with
specific antibodies and visualised by fluorescence microscopy [17]
(Figure 3A). We initially assessed the effect of HU treatment on
replication fork processivity in Atrxflox and Atrxnull cells using this
technique. Cells were pulsed for 10 minutes with IdU, followed by
a 40-minute incubation with CldU and 1mM HU. For each
replication fork the processivity was determined as the ratio of the
length of IdU:CldU labelled DNA; higher ratios corresponding to
lower processivity. While the majority of replication forks
exhibited a comparable reduction in processivity upon HU
treatment (Figure 3B), the distribution was skewed with a
significantly higher (p = 0.0021) frequency of very slow replicating
forks in the Atrxnull cells. This indicates that, although not required
globally for replication fork processivity, efficient replication of a
subset of genomic loci is dependent on ATRX. In addition, this
DNA fibre technique allows for the identification five major
replication intermediates; elongating forks, origin firing, termina-
tion events, interspersed origins and stalled replication forks
(Figure 3C) [17,18,19]. A reproducible increase in the proportion
of stalled replication forks was observed in the Atrxnull cells relative
to the Atrxflox cells (Figure 3D). After replication stress was induced
by treatment with HU during the IdU pulse a marked increase in
the frequency of stalled replication forks was observed in both the
Atrxflox and Atrxnull cells (Figure 3E). A small decrease in origin
firing was observed in the Atrxnull cells (Figure 3D) but this was not
apparent upon treatment with HU in the IdU pulse (Figure 3E).
No consistent change was observed in the occurrence of the other
replication intermediates. Comparable results were obtained using
the second Atrxflox and Atrxnull clones (Figure S1E), suggesting that
the differences were not attributable to a clonal effect. It is
apparent that in the absence of ATRX, DNA replication is
perturbed with an extended S-phase, an increase in stalled forks
and a DDR, reflecting the presence of DSBs presumably arising
from collapse of the replication fork.
Loss of ATRX function does not affect telomere
maintenance in mouse ES cells
It has recently been shown that ATRX mutations or the
absence of ATRX protein is an almost invariant finding in cell
lines exhibiting the ALT phenotype and that various cancers with
features consistent with the ALT phenotype are frequently
associated with mutations in ATRX, DAXX and/or H3.3
[12,14,20]. Since replication fork stalling is a known trigger of
recombination, the possibility that ATRX may normally repress
this pathway in primary mouse ES cells was next considered. No
marked changes in telomere length were detectable in Atrxnull cells
relative to the Atrxflox cells using both quantitative FISH, which
gave median telomere intensities of 1020 (A.U.) for both Atrxflox
and Atrxnull cells (Figure 4A and B) and terminal restriction
fragment length (Figure 4C) analyses. ALT is characteristically
associated with heterogeneous telomere lengths and these data
therefore infer that knockout of ATRX in mouse ES cells is
insufficient to trigger the ALT pathway. The cellular context,
including the telomerase negative status of cells, must therefore be
an important additional factor in the development of the ALT
pathway. Consistent with this, knockdown of ATRX in HeLa cells
also fails to initiate the ALT pathway [20].
ATRX interacts with the MRN complex
It is therefore clear that loss of ATRX function alone is
insufficient to trigger the ALT pathway. To explore further the
mechanism by which ATRX prevents replication stress/genomic
instability and suppresses the ALT pathway we used co-
immunoprecipitation to identify proteins interacting with endog-
enous ATRX. Using a polyclonal antibody raised to the C-
terminus of ATRX (H300), ATRX interaction partners were
immune-isolated from a HeLa nuclear extract and resolved by
SDS PAGE gel electrophoresis. Three major bands were analysed
by mass spectrometry (Figure 5A). In addition to ATRX and its
known partner DAXX, a third protein (RAD50) was identified as
a novel interaction partner. The co-immunoprecipitation reaction
ATRX in DNA Replication
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Figure 1. Loss of ATRX triggers a DNA damage response. (A) Representative images for immuno-FISH analysis showing colocalisation
between 53BP1 and telomeres. Full data sets are available at http://sara.molbiol.ox.ac.uk/public/staylor/53BP1_Tel2 and http://sara.molbiol.ox.ac.uk/
public/staylor/53BP1_Tel3. (B),(C) 53BP1 foci and 53BP1 telomere colocalising foci were scored using the JACoP plugin for ImageJ from a total of 105
Atrxflox and 115 Atrxnull cells. Statistical significance was determined using a Mann Whitney test. (D) Representative images of COMETs. (E)
ATRX in DNA Replication
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was repeated using an antibody raised to the N-terminus of ATRX
(39F) and in this case all immune-isolated protein was subject to
identification by mass spectrometry. RAD50, MRE11 and NBS1,
the three components of the MRN complex [21], were identified
(Figure 5B). Moreover, immunoprecipitation with an antibody to
DAXX also recovered RAD50, MRE11 and NBS1 (Figure 5B).
Immunoblotting with RAD50, MRE11 and NBS1 specific
antibodies confirmed the identification of these proteins as ATRX
interaction partners (Figure 5C). These interactions were main-
tained in the presence of ethidium bromide, suggesting that the
interactions were direct rather than DNA mediated (Figure 5C).
The interaction between ATRX and RAD50 was confirmed in the
reverse co-immunoprecipitation reaction using a RAD50 mono-
clonal antibody (Figure 5C).
The MRN complex has many known functions including:
double strand break repair (via both HR and NHEJ) and the
restart of stalled replication forks [22,23]. We addressed whether
ATRX normally co-localises with the MRN complex by dual
indirect immuno-fluoresence in HeLa cells. Approximately 5 –
10% of unsynchronised HeLa cells exhibit nuclear foci containing
both RAD50 and MRE11 associated with DNA damage. In 88%
of these cells, ATRX co-localised with at least one of these
RAD50/MRE11 foci (Figure 5D, E and F). Furthermore, all
subnuclear foci in which ATRX was associated with RAD50/
MRE11 were found in nuclei which stained positive for PCNA
(Figure 5G), indicating that the association of ATRX and the
MRN complex occurs during S phase. Analogous results were
obtained in mES cells, suggesting that this interaction is not
confined to HeLa cells (Figure S2). Together these data provide
evidence that the ATRX/DAXX complex interacts with the
MRN complex during DNA replication and is likely to play a
direct role in facilitating this process.
Discussion
Here we show that a conditional deletion of full length ATRX
in primary mouse ES cells undergoing replicative stress, leads to a
prolongation in S-phase, concomitant accumulation of gamma-
H2AX and an increase in fork stalling. Notably, loss of ATRX
elicits an apparent defect in late S phase, which likely includes
replication of repetitive, heterochromatic sites, known targets of
ATRX binding [10]. In accordance with this, ATRX is not
generally required for fork processivity but instead appears to be
required for the efficient replication of a subset of genomic loci.
Although in this study we were unable to identify these sites it is
likely that they represent late replicating ATRX target sites.
This model has gained support from a number of complemen-
tary studies. Ablation of ATRX in mouse myoblasts delayed their
progression in S phase and led to an accumulation of DNA
damage including telomere fragility [6] and similar findings were
observed in a study involving neuroprogenitors [24]. In a further
advance, a somatic knockout of ATRX in a colorectal cell line
exhibited increased sensitivity to hydroxyurea and aphidicolin
suggesting that in the absence of ATRX there is an increase in
replicative stress in this cellular context [25]. Taken together with
the findings presented here it is clear that ATRX has a general
role in facilitating DNA replication in multiple cellular environ-
ments and that this may in part account for why loss of ATRX
function results in such disparate pathologies. Given the role
reported here in ES cells it is likely that this function is also
relevant in normal development.
A large proportion of ATRX target sites are predicted to adopt
non-B form secondary structures, including the G-quadruplex
conformation [10]. Accumulating evidence suggests that the
presence of such secondary structures serve as a barrier to
replication fork progression, leading to fork stalling or collapse
[26,27,28]. It is therefore tempting to think that ATRX is
responsible for preventing the formation and/or accumulation of
such structures at its repetitive target sites, thereby facilitating
replication. This hypothesis is supported by the particular
sensitivity of Atrxnull cells to hydroxyurea, a replication inhibitor
that increases the likelihood of G4 formation. Moreover, in line
with these observations, Atrxnull neuroprogenitor cells have recently
been shown to be sensitive to the G-quadruplex stabilising ligand
telomestatin [24], lending weight to the notion that ATRX aids
the replication of G-quadruplex structures. Here we have shown
that ATRX does not itself appear to possess G-quadruplex
unwinding activity (Figure S3) suggesting that ATRX must
overcome these impediments indirectly, perhaps by facilitating
histone H3.3 deposition to maintain DNA in the B-form, or
alternatively by promoting fork bypass via a process such as
template switching. Further work is needed to determine where
ATRX functions, physically and temporally, in relation to the
replication fork.
Interestingly, a role for ATRX in facilitating replication through
potential G-quadruplex forming sequences may shed light on its
recently ascribed role as a tumor suppressor in a specific subset of
malignancies that depend on a telomerase-independent pathway
of telomere maintenance called the ‘alternative lengthening of
telomeres’ (ALT) pathway [12,14,20]. ALT is thought to depend
on recombination between telomeric sequences [29] and therefore
one could envisage that the presence of G-quadruplex structures in
the absence of ATRX and subsequent fork stalling may serve as a
trigger for HR. We note that telomere length remains largely
unperturbed in the Atrxnull cells, thereby suggesting that loss of
ATRX alone is not sufficient to trigger ALT in this cellular
context. It is therefore obviously of interest to determine the
additional requirements for ALT activation.
By co-immunoprecipitation we demonstrate an interaction
between endogenous ATRX and components of the MRE11-
RAD50-NBS1 (MRN) complex during S phase and a similar
finding, using an expressed tagged ATRX transgene, has recently
been reported[25]. Like ATRX, the MRN complex localises to
telomeres during the S and G2 phases of the cell cycle [30,31] and
interestingly G-quadruplexes are a preferred substrate for
MRE11[32]. MRN has many known functions important for
genomic stability and replication, including the repair of double
strand breaks (via both HR and NHEJ) and the restart of stalled
replication forks. Furthermore the MRN complex is required for
ALT [33,34] It is likely that the interaction between ATRX and
MRN is important to the role of ATRX in facilitating replication
and genomic stability [22,23]. It will be of considerable interest in
future studies to determine the mechanism by which ATRX
suppresses ALT and whether the interaction between ATRX and
MRN plays a role in this process.
Quantitation of DNA DSBs by COMET assay represented by the proportion of DNA in the COMET ‘‘tail’’ (n = 50). Exposure to gamma-irradiation was
used as a positive control. (F) Cellular sensitivity of Atrxflox and Atrxnull mES cells to ionising radiation (IR), hydroxyurea (HU), Aphidicolin and Cisplatin
as measured by clonogenic survival assay. Error bars indicate 6 SEM from a minimum of three independent experiments.
doi:10.1371/journal.pone.0092915.g001
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Figure 2. Loss of ATRX results in a prolonged S-phase. (A) Cell cycle profile for Atrxflox and Atrxnull mES cells. (B) Percentage of cells in G1, S and
G2/M cells at various time points following release from G1 block are shown as determined by FACs analysis. Error bars indicate 6 SEM from three
independent experiments. (C) Western blot and quantitation from 3 biological replicates (D) to assess levels of gamma-H2AX in histones purified from
Atrxflox and Atrxnull mES cells at the indicated time points. This showed an elevated DDR, reflected by elevated gamma-H2AX, in Atrxnull cells as
compared to the Atrxflox cells. U = unsynchronised cells. Histone H3 is shown as the loading control. Error bars indicate 6 SEM.
doi:10.1371/journal.pone.0092915.g002
ATRX in DNA Replication
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Materials and Methods
Cell cycle synchronisation and analysis
Cell cycle synchronisation was performed using a thymidine
aphidicolin double block as previously described [35]. 30 mins
prior to each time point cells were incubated with 10 mM BrdU.
BrdU incorporation and DNA content were assessed by FACs
analysis using propidium iodide staining, anti-BrdU antibody
(Abcam ab6326) and goat anti-rat A488 secondary antibody
(Invitrogen A11006). Histones from each time point were
solubilised in 2M HCl and precipitated in acetone overnight at
220uC. Western blotting was performed using anti-gamma-
H2AX (Millipore 05-636) and anti-histone H3 antibody (Abcam
ab1791).
Figure 3. ATRX deficient cells show an increase in replication fork stalling and DNA double strand breaks. (A) Representative image of
actual fibres from Atrxflox mES cells. (B) Replication fork processivity in Atrxflox and Atrxnull mES cells shown as a box whisker plot of the ratio in length
of IdU and CldU labelled DNA for individual replicons (n = 259 for Flox and 359 for Null). Statistical significance was determined using a Mann Whitney
test. (C) Representative images of five classes of replication intermediates identifed by DNA fibre analysis in this study. (D), (E) Relative frequency of
replication intermediates in Atrxflox and Atrxnull mES cells without (D) and with hydroxyurea treatment (E) during the IdU pulse. Over 1000 fibres
totalled from three independent replicates were scored per experiment and error bars indicate 6 SEM.
doi:10.1371/journal.pone.0092915.g003
ATRX in DNA Replication
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COMET assay
mES cells were treated with ionising radiation at the dosages
specified and the Comet assay was performed as described in [36]
with the following modifications. Following electrophoresis and
washes in Tris buffer slides were washed in 70% ethanol and air-
dried prior to staining with SybrGold (Invitrogen S1-494). 50
COMETs from each cell type/dosage were analysed using Komet
6 (Andor) software.
Immunoisolation of ATRX interaction partners
Immunoprecipitations were performed from 2 to 4 mg HeLa
nuclear extract (Cilbiotech) in IP buffer (20 mM HEPES pH 7.4,
1% Triton X-100, 150 mM NaCl, 1 mM EDTA, 1 mM EGTA +
protease inhibitor cocktail). Immunoprecipitations were performed
overnight at 4uC using 3 mg anti-ATRX antibody (sc-15408) and
4 mg anti-RAD50 antibody (Abcam ab89) with Protein A or G
agarose beads (Millipore 16-125, 16-201) in the presence or
absence of 100 mg/ml ethidium bromide. Beads were washed 4
times in IP buffer and bound proteins eluted into SDS loading
buffer (Laemmli) by heating at 90uC for 5 mins. Western blotting
was performed using the following additional antibodies; anti-
MRE11 (Abcam ab214), anti-NBS1 (Santa Cruz sc-11431).
Terminal restriction fragment analysis
Telomere length was determined by terminal restriction length
analysis [37]. 5mg of high molecular weight DNA was digested
with HinfI and RsaI then separated by pulse field gel electropho-
resis in 1% agarose and 0.5xTBE at 6V/cm for 15hrs with switch
times of 0.1–20 secs for mouse and 0.1–6.0 secs for human DNA.
After blotting the filter was probed with radioactively labelled
telomeric sequence.
Immunofluorescence and telomere FISH
Cells grown on coverslips were prepared for IF by standard
procedures. The following antibodies were used for immunostain-
ing: anti-ATRX (Santa Cruz sc-15408); anti-ATRX 39f [38]; anti
MRE11 (Abcam ab214); anti-MRE11 (Calbiochem PC388); anti-
RAD50 (Abcam ab89); anti-PCNA (Santa Cruz sc-9857); anti-
RPA32 (S33) (Bethyl A300-246A); anti-NBS1 (BD Biosciences
611871); anti-53BP1 (Novus Biologicals NB100-305); For MRN
co-localisation studies cells were pre-permeabilised prior to
fixation with ice cold 0.5% Triton X-100. For MRE11/ATRX/
PCNA co-localisation in mES cells, cells were attached to
coverslips via poly-l-lysine treatment prior to pre-permeabilisation.
Figure 4. Loss of ATRX does not affect telomere maintenance in mouse ES cells. (A) Representative image of a telomere FISH performed on
a metaphase spread. (B) Quantitation of telomere fluorescence intensity in Atrxflox and Atrxnull mES cells from .7000 telomeres for each cell type. (C)
Terminal restriction length analysis of two independent clones (1, IF12 and 2, IG11) after digestion with HinfI and RsaI. Digested DNA was probed with
a radiolabelled telomeric repeat.
doi:10.1371/journal.pone.0092915.g004
ATRX in DNA Replication
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Telomere FISH was performed subsequent to antibody incubation
using Telomere PNA FISH Kit/Cy3 (Dako K5326).
Bioinformatics analysis
Image analysis was done using custom perl processing scripts
that called various ImageJ macros to allow filtering and automatic
thresholding methods to segment nuclei and then identify foci per
nucleus. The JACoP [39] plugin was used to examine coincident
colocalisation and distance based colocalisation (DBC). Using
ImageJ macros and Perl scripts a montage for each cell was
generated which included the segmented nuclei, auto-thresholded
images for each channel, original grey scale images for each
channel and the JACoP DBC and CC. The images were visualised
and analysed using the HTML5 PivotViewer (manuscript in
preparation). The entire process was automated and all scripts are
available on request. PivotViewer allowed the rapid analysis and
review of the many hundreds of images generated from these
analyses.
G4 unwinding assay
This assay was performed according to a previously published
method [40].
Cell survival assay
150-300 mES cells were grown for 24h before treatment with
the specified DNA damaging agents or replication inhibitors. After
3 or 4 days, colonies were stained with 1% w/v methylene blue
50% ethanol and counted.
DNA fibre analysis
For fibre analysis mES cells were incubated with 25 mM IdU for
10 mins or 90 mins in the presence of 1 mM hydroxyurea,
followed by a 10 or 20 min incubation with 250 mM CldU
respectively. For assessment of fork processivity mES cells were
incubated with IdU for 10 mins followed by a 40 min incubation
with CldU in the presence of 1 mM hydroxyurea. Spreading and
visualisation of fibres was performed as previously described [17].
Supporting Information
Figure S1 (A) Representative images of cell cycle profile for
Atrxflox and Atrxnull mES cells following 8 hours release from
aphidicolin block. Black box shows late replicating population. (B)
Percentage of late replicating cells as determined by FACs
following 2, 6 and 8 hours post release from aphidicolin block.
Error bars indicate 6 SEM from three independent experiments
(C) Immunoblot and quantitation (D) to assess levels of gamma-
H2AX in histones purified from Atrxflox and Atrxnull mES cells (clone
2) at the indicated time points. This showed an elevated DDR,
reflected by elevated gamma-H2AX, in Atrxnull cells as compared
to the Atrxflox cells. U = unsynchronised cells. Histone H3 is shown
as the loading control. Error bars indicate 6 SEM. (E) Results of
fibre analysis showing relative frequencies of replication interme-
diates in in Atrxflox and Atrxnull mES cells (clone 2) with hydroxyurea
treatment during the IdU pulse.
(TIF)
Figure S2 Representative images for immunofluorescence in
wildtype mES cells showing 3 way co-localisation between PCNA,
MRE11 and ATRX using an N-terminal specific ATRX
antibody. Nuclei are outline with a dashed white line.
(TIF)
Figure S3 Unwinding assay for G4 DNA. Recombinant ATRX
[41] was compared with BLM for its ability to unwind a G4
substrate. Both proteins were used in a 2 fold dilution series.
ATRX binds G4 giving rise to a shifted signal but unlike BLM
does not unwind the G4 DNA.
(TIF)
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